Company: STAA
Filing Date: 2025-10-14
Form Type: 8-K
Source: 0001193125-25-238127
Chunk: 0

Company: STAAR SURGICAL CO
Filing Date: 2025-10-14
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01      Other Events.  

As previously disclosed, on August 4, 2025, STAAR Surgical Company (“ STAAR”), Alcon Research, LLC (“ Alcon”) and Rascasse Merger Sub, Inc., a wholly owned subsidiary of Alcon (“ Merger Sub”), entered into an Agreement and Plan of Merger (the “ Merger Agreement”), pursuant to which, among other things and subject to the terms and conditions therein, Merger Sub will merge with and into STAAR, with STAAR surviving the merger as a direct, wholly owned subsidiary of Alcon (such transaction, the “ Merger”).

STAAR filed a definitive proxy statement (the “ Proxy Statement”) with the U. S. Securities and Exchange Commission on September 16, 2025 for the solicitation of proxies in connection with the special meeting of STAAR’s stockholders, to be held on October 23, 2025, to vote upon, among other things, a proposal to adopt the Merger Agreement.